Contact our team
Science platform
Scientific Foundation

Engineering metabolic diversity.

Valgogenix commercializes high-purity bioactive compounds synthesized in closed-loop photobioreactors, bridging clinical-grade molecular engineering with industrial scale-up.

Thermodynamic Reality

Closed-loop synthesis, verified purity.

We program specific strains in sterile photobioreactors to yield precise molecular profiles with carbon-negative thermodynamic efficiency.

Macro close-up of sterile glass photobioreactors with bubbling green cultures under cool crisp laboratory light, 50mm scientific photography
Macro close-up of sterile glass photobioreactors with bubbling green cultures under cool crisp laboratory light, 50mm scientific photography
Operational Rigor

Closed-loop photobioreactor technology.

Our Zurich-based facility operates proprietary bioreactors that maintain absolute sterile control over cellular environments.

By maximizing photosynthetic efficiency, we synthesize clinical-grade compounds with total molecular purity.

High-contrast monochrome portrait of a female metabolic engineer in a sterile white laboratory setting, 50mm crisp scientific photography
High-contrast monochrome portrait of a female metabolic engineer in a sterile white laboratory setting, 50mm crisp scientific photography
High-contrast monochrome portrait of a male bioprocess engineer in a cleanroom environment, 50mm crisp scientific photography
High-contrast monochrome portrait of a male bioprocess engineer in a cleanroom environment, 50mm crisp scientific photography
High-contrast monochrome portrait of a female biotech executive in a modern minimal office, 50mm crisp scientific photography
High-contrast monochrome portrait of a female biotech executive in a modern minimal office, 50mm crisp scientific photography
The Founders

Academic and operational leadership.

Our executive team combines decades of deep-tech metabolic engineering with proven industrial scale-up expertise to drive microalgae commercialization.

Dr. Elena Rostova

Marcus Vance

Dr. Sophia Chen

Chief Scientific Officer. Former ETH Zurich researcher specializing in microalgae strain programming and metabolic pathway optimization for clinical applications.

VP of Engineering. Led scale-up operations for three industrial bioreactor facilities, specializing in closed-loop thermodynamic efficiency and sterile control systems.

Chief Executive Officer. Venture partner and biochemist with fifteen years of experience licensing therapeutic bioactive compounds to global biopharma scouts.